• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER, INC (IRWINDALE) NOGA-STAR¿ CARDIOLOGY CATHETER; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER, INC (IRWINDALE) NOGA-STAR¿ CARDIOLOGY CATHETER; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING Back to Search Results
Model Number 120707S
Device Problem Insufficient Information (3190)
Patient Problems Atrial Fibrillation (1729); Bradycardia (1751); Coagulation Disorder (1779); Death (1802); Swelling (2091); Electrolyte Imbalance (2196); Cardiogenic Shock (2262); Respiratory Failure (2484); No Code Available (3191)
Event Date 05/13/2015
Event Type  Death  
Event Description
It was reported that the (b)(6) male patient had undergone the study procedure using nogastar catheter (lv mapping and endomyocardial stem cell therapy vs.Placebo) on (b)(6) 2015 which was a part of dream-hf clinical trial.The patient was in stable condition prior to being discharged from hospital.The patient admitted to a hospital again for leg swelling and generalized weakness but no association to fever, chills, pnd, orthopnea, or chest pain.Patient¿s problems at the time of visit included hyperkalemia, acute kidney injury, cardiogenic shock, atrial fibrillation, acute respiratory failure, hyponatremia, coagulopathy, and bradycardia.The patient had expired on (b)(6) 2015.There was no autopsy was requested.There were no complications related to the study procedure and no anomalies were found on the catheter during the case.The physician¿s opinion regarding the cause of this adverse event is that this is not procedure related.However, since the nogastar catheter was present during this procedure, bwi takes conservative approach and reports this event under the nogastar catheter.
 
Manufacturer Narrative
The device history record (dhr) was reviewed and no anomalies were found related to this complaint.In addition, the dhr review verifies that the device was manufactured in accordance with documented specification and procedures.(b)(6).(b)(4).
 
Manufacturer Narrative
(b)(4).It was reported that the (b)(6) male patient had undergone the study procedure using nogastar catheter (lv mapping and endomyocardial stem cell therapy vs.Placebo) on (b)(6) 15 which was a part of (b)(6) clinical trial.The patient was in stable condition prior to being discharged from hospital.The patient admitted to a hospital again for leg swelling and generalized weakness but no association to fever, chills, pnd, orthopnea, or chest pain.Patient¿s problems at the time of visit included hyperkalemia, acute kidney injury, cardiogenic shock, atrial fibrillation, acute respiratory failure, hyponatremia, coagulopathy, and bradycardia.The patient had expired on (b)(6) 2015.The returned device was visually inspected upon receipt and it was found in normal conditions.Per the event, the catheter was tested for electrical performance, temperature response and stockert compatibility and it was found within specifications.Furthermore, an irrigation test was performed and the catheter passed, no occlusion was observed.A deflection test was performed and the catheter passed.The catheter was also evaluated for carto 3.The catheter was recognized by carto 3 system, no error messages were displayed and the catheter was properly visualized.The force feature was evaluated and passed.The device history record (dhr) was reviewed and no anomalies were found related to this complaint.In addition, the dhr review verifies that the device was manufactured in accordance with documented specification and procedures.The catheter passed all specifications patient cause of decease remains unknown.
 
Manufacturer Narrative
The bwi failure analysis lab received the device for evaluation.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOGA-STAR¿ CARDIOLOGY CATHETER
Type of Device
CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING
Manufacturer (Section D)
BIOSENSE WEBSTER, INC (IRWINDALE)
15715 arrow highway
irwindale CA 91706
Manufacturer (Section G)
BIOSENSE WEBSTER, INC (IRWINDALE)
15715 arrow highway
irwindale CA 91706
Manufacturer Contact
shahe garabedian
9098397362
MDR Report Key4826367
MDR Text Key5838690
Report Number2029046-2015-00155
Device Sequence Number1
Product Code DRF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K954390
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 05/20/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2017
Device Model Number120707S
Device Catalogue Number120707S
Device Lot Number17020340M
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/18/2015
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 05/20/2015
Initial Date FDA Received06/09/2015
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received07/07/2015
07/15/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/09/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age48 YR
Patient Weight79
-
-